Amgen, headquartered in Thousand Oaks, California, is a biotechnology company employing 26,700 staff, focusing on developing human therapeutics for high unmet medical needs. Its product portfolio includes Aranesp, ENBREL, and Prolia, among others.
AMGN has been in the news recently: Amgen, as a major player in the pharmaceutical industry, may be affected by President Trump's call for drug price reductions amid rising costs. Additionally, the current economic climate and concerns about stagflation could impact investor sentiment toward biotechnology stocks like Amgen.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
